Evidence map›Paper›PMID 39929541›Full record

ArticleAJNR. American journal of neuroradiology2025

Altered Functional Connectivity and Amyloid Deposition in Posttraumatic Stress Disorder-Associated Cognitive Impairment.

Richard Dagher, Parisa Arjmand, Daniel A Stevens, Max Wintermark, Haris I Sair, Vivek Yedavalli, Licia P Luna, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Richard DagherFrom the Department of Neuroradiology (R.D., M.W.), The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID https://orcid.org/0009-0001-7666-2989
Parisa ArjmandDepartment of Radiology (P.A.), University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, Ohio.
Daniel A StevensDepartment of Psychiatry and Behavioral Sciences (D.A.S.), Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID https://orcid.org/0000-0002-7076-794X
Max WintermarkFrom the Department of Neuroradiology (R.D., M.W.), The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID https://orcid.org/0000-0002-6726-3951
Haris I SairRussell H. Morgan Department of Radiology and Radiological Science (H.I.S., V.Y., L.P.L,), Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID https://orcid.org/0000-0002-5077-0471
Vivek YedavalliRussell H. Morgan Department of Radiology and Radiological Science (H.I.S., V.Y., L.P.L,), Johns Hopkins University School of Medicine, Baltimore, Maryland.
Licia P LunaRussell H. Morgan Department of Radiology and Radiological Science (H.I.S., V.Y., L.P.L,), Johns Hopkins University School of Medicine, Baltimore, Maryland lluna6@jh.edu.ORCID https://orcid.org/0000-0003-3539-4831
Alzheimer’s Disease Neuroimaging Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePosttraumatic stress disorder (PTSD) has been linked to an increased risk of cognitive impairment and dementia, with neuroinflammation, metabolic dysfunction, and neuropathologic markers such as β-amyloid and τ implicated as potential mechanisms. However, the roles of altered functional connectivity and amyloid deposition as biomarkers in the progression of cognitive impairment among patients with PTSD remain unclear, with limited and often conflicting evidence from existing neuroimaging studies. This study examines these neuroimaging markers in patients with PTSD with and without cognitive impairment to better understand the neurobiologic pathways contributing to cognitive decline in PTSD. MATERIALS AND

methodsData were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Department of Defense (DOD) databases. A cohort of 178 age-matched male subjects was divided into 4 groups: posttraumatic stress disorder with cognitive impairment (PTSD-CI); posttraumatic stress disorder and cognitively normal (PTSD-CN); non-posttraumatic stress disorder with cognitive impairment (NPTSD-CI); and non-posttraumatic stress disorder and cognitively normal (NPTSD-CN). All subjects underwent resting-state functional MRI and amyloid PET imaging, with PTSD diagnosis and cognitive impairment (CI) confirmed through clinical assessments. Functional connectivity was analyzed by using the CONN Toolbox, and amyloid burden was quantified via standardized uptake value ratios. Analyses controlled for demographic and genetic factors, including age, education,

resultsCompared with the NPTSD-CN group, the PTSD-CI group showed significantly increased amyloid uptake in the temporal and parietal lobes, with corresponding functional connectivity increase between the bilateral temporal lobes and parietal operculum. In contrast, PTSD-CN patients exhibited no significant amyloid increase but showed increased connectivity between the salience network, postcentral gyri, and sensorimotor areas, and decreased connectivity between the sensorimotor network and anterior cingulate cortex. These distinct patterns suggest differing neurobiologic profiles between PTSD-CI and PTSD-CN patients.

conclusionsThe findings suggest that elevated amyloid and altered connectivity patterns are associated with cognitive impairment in PTSD, particularly in the temporal and parietal regions. In contrast, PTSD without cognitive decline was associated with functional connectivity changes in salience and sensorimotor networks but no increased amyloid deposition. This study underscores the importance of neuroimaging biomarkers in understanding PTSD-related cognitive decline and suggests avenues for further investigation into the mechanistic pathways involved.

Indexed as

Amyloid beta-PeptidesBrainCognitive DysfunctionStress Disorders, Post-TraumaticAgedBiomarkersHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyAmyloid beta-PeptidesBiomarkers

Identifiers

PMID39929541
PMCPMC12453491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.